COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2257: Articles 22561-22570  | Next

The influence of major S protein mutations of SARS-CoV-2 on the potential B cell epitopes
Yuan, X., Li, L.
10.1101/2020.08.24.264895 — Posted: 2020-08-24
Induction of SARS-CoV-2 protein S-specific CD8+ T cells in the lungs of gp96-Ig-S vaccinated mice
Fisher, E., Padula, L., Podack, K., O'Neill, K., Seavey, M. M., Jayaraman, P., Jasuja, R., Strbo, N.
10.1101/2020.08.24.265090 — Posted: 2020-08-24
Flagellin from Pseudomonas aeruginosa increases the expression of the SARS-CoV2 entry protease TMPRSS2 in airway epithelial cells
Ruffin, M., Bigot, J., Calmel, C., Corvol, H., Balloy, V., Guillot, L.
10.1101/2020.08.24.264564 — Posted: 2020-08-24
The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting viral replication-transcription complex in culture cells
Matsuyama, S., Kawase, M., Nao, N., Shirato, K., Ujike, M., Kamitani, W., Shimojima, M., Fukushi, S.
10.1101/2020.08.22.258459 — Posted: 2020-08-24 Discussion: Offsite
SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model
Haagmans, B. L., Noack, D., Okba, N. M. A., LI, W., Wang, C., Bestebroer, T., de Vries, R., Herfst, S., de Meulder, D., van Run, P., Lamers, M. M., Rijnders, B., Rokx, C., van Kuppeveld, F. J. M., Grosveld, F., Drabek, D., GeurtsvanKessel, C., Koopmans, M., Bosch, B. J., Kuiken, T., Rockx, B.
10.1101/2020.08.24.264630 — Posted: 2020-08-24
An hACE2 peptide mimic blocks SARS-CoV-2 Pulmonary Cell Infection
Karoyan, P., Vieillard, V., Odile, E., Denis, A., Gomes-Morales, L., Grondin, P., Lequin, O.
10.1101/2020.08.24.264077 — Posted: 2020-08-24 Discussion: Onsite
Dynamics of the N-terminal domain of SARS-CoV-2 nucleocapsid protein drives dsRNA melting in a counterintuitive tweezer-like mechanism
Caruso, I. P., Sanches, K., Da Poian, A., Pinheiro, A., Almeida, F. C. L.
10.1101/2020.08.24.264465 — Posted: 2020-08-24
A negative feedback model to explain regulation of SARS-CoV-2 replication and transcription
Shan, G., Zhi, C., Xiufeng, J., Fang, W., Yibo, X., Hao, Z., Chang, L., Jishou, R., Guangyou, D., Xin, L.
10.1101/2020.08.23.263327 — Posted: 2020-08-24
Versatile, Multivalent Nanobody Cocktails for Highly Efficient SARS-CoV-2 Neutralization
Shi, Y.
10.1101/2020.08.24.264333 — Posted: 2020-08-24 Discussion: Onsite
Discovery of drugs to treat cytokine storm-induced cardiac dysfunction using human cardiac organoids
Mills, R. J., Humphrey, S. J., Fortuna, P. R., Quaife-Ryan, G. A., Mehdiabadi, N. R., Devilee, L., Voges, H. K., Reynolds, L. T., Krumeich, S., Mathieson, E., Griffen, B., Titmarsh, D. M., Porrello, E. R., Smyth, M. J., Engwerda, C. R., MacDonald, K. P., Bald, T., James, D. E., Hudson, J. E.
10.1101/2020.08.23.258574 — Posted: 2020-08-24 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).